These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8831262)

  • 1. [Catalytic antibodies: generation of a new class of protein catalysts exploiting the immune system].
    Fujii I
    Yakugaku Zasshi; 1996 Aug; 116(8):606-21. PubMed ID: 8831262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common ancestry for multiple catalytic antibodies generated against a single transition-state analog.
    Miyashita H; Hara T; Tanimura R; Tanaka F; Kikuchi M; Fujii I
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6045-9. PubMed ID: 8016113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
    Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
    J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
    Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I
    J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-directed mutagenesis of active site contact residues in a hydrolytic abzyme: evidence for an essential histidine involved in transition state stabilization.
    Miyashita H; Hara T; Tanimura R; Fukuyama S; Cagnon C; Kohara A; Fujii I
    J Mol Biol; 1997 Apr; 267(5):1247-57. PubMed ID: 9150409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse structural solutions to catalysis in a family of antibodies.
    Gigant B; Tsumuraya T; Fujii I; Knossow M
    Structure; 1999 Nov; 7(11):1385-93. PubMed ID: 10574796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens.
    Odenbaugh AL; Helms ED; Iverson BL
    Bioorg Med Chem; 2000 Feb; 8(2):413-26. PubMed ID: 10722164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of catalytic antibody repertoire in autoimmune mice.
    Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):213-33. PubMed ID: 12379363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective chemotherapeutic strategies using catalytic antibodies: a common pro-moiety for antibody-directed abzyme prodrug therapy.
    Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):269-81. PubMed ID: 12379367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prodrug activation via catalytic antibodies.
    Miyashita H; Karaki Y; Kikuchi M; Fujii I
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5337-40. PubMed ID: 8506382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. At the crossroads of chemistry and immunology: catalytic antibodies.
    Lerner RA; Benkovic SJ; Schultz PG
    Science; 1991 May; 252(5006):659-67. PubMed ID: 2024118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis.
    Wentworth P; Liu Y; Wentworth AD; Fan P; Foley MJ; Janda KD
    Proc Natl Acad Sci U S A; 1998 May; 95(11):5971-5. PubMed ID: 9600901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune recognition, antigen design, and catalytic antibody production.
    Tramontano A
    Appl Biochem Biotechnol; 1994; 47(2-3):257-73; discussion 273-5. PubMed ID: 7944342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic antibodies.
    Tramontano A; Janda KD; Lerner RA
    Science; 1986 Dec; 234(4783):1566-70. PubMed ID: 3787261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From molecular diversity to catalysis: lessons from the immune system.
    Schultz PG; Lerner RA
    Science; 1995 Sep; 269(5232):1835-42. PubMed ID: 7569920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of biomimetic catalysts by molecular imprinting in synthetic polymers: the role of transition state stabilization.
    Wulff G; Liu J
    Acc Chem Res; 2012 Feb; 45(2):239-47. PubMed ID: 21967389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten.
    Tawfik DS; Lindner AB; Chap R; Eshhar Z; Green BS
    Eur J Biochem; 1997 Mar; 244(2):619-26. PubMed ID: 9119032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity?
    Tawfik DS; Chap R; Green BS; Sela M; Eshhar Z
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2145-9. PubMed ID: 7892238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for antibody catalysis of a disfavored ring closure reaction.
    Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
    Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.